| Symbol |
Name |
Standardized Value |
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
3.027
|
|
CRP
|
C-reactive protein, pentraxin-related
|
2.871
|
|
ALB
|
albumin
|
2.841
|
|
MLN
|
motilin
|
2.76
|
|
SLC26A9
|
solute carrier family 26 (anion exchanger), member 9
|
2.747
|
|
ATP12A
|
ATPase, H+/K+ transporting, nongastric, alpha polypeptide
|
2.598
|
|
ATP4A
|
ATPase, H+/K+ exchanging, alpha polypeptide
|
2.576
|
|
IL6
|
interleukin 6
|
2.445
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
2.424
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
2.358
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
2.303
|
|
TNF
|
tumor necrosis factor
|
2.302
|
|
IL1B
|
interleukin 1, beta
|
2.301
|
|
MLNR
|
motilin receptor
|
2.284
|
|
SLC6A14
|
solute carrier family 6 (amino acid transporter), member 14
|
2.23
|
|
F2
|
coagulation factor II (thrombin)
|
2.204
|
|
GUCY2C
|
guanylate cyclase 2C
|
2.192
|
|
TAC1
|
tachykinin, precursor 1
|
2.18
|
|
VIP
|
vasoactive intestinal peptide
|
2.17
|
|
GHSR
|
growth hormone secretagogue receptor
|
2.148
|
|
SST
|
somatostatin
|
2.146
|
|
SLC9A3
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3
|
2.135
|
|
INS
|
insulin
|
2.123
|
|
IL10
|
interleukin 10
|
2.115
|
|
OPRM1
|
opioid receptor, mu 1
|
2.096
|
|
ERAS
|
ES cell expressed Ras
|
2.073
|
|
GUCA2B
|
guanylate cyclase activator 2B (uroguanylin)
|
2.062
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
2.039
|
|
GCG
|
glucagon
|
2.025
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
1.993
|
|
FABP2
|
fatty acid binding protein 2, intestinal
|
1.98
|
|
GUCA2A
|
guanylate cyclase activator 2A (guanylin)
|
1.977
|
|
GAST
|
gastrin
|
1.968
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
1.953
|
|
NPR3
|
natriuretic peptide receptor 3
|
1.94
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
1.939
|
|
MPO
|
myeloperoxidase
|
1.926
|
|
IFNG
|
interferon, gamma
|
1.909
|
|
CD4
|
CD4 molecule
|
1.905
|
|
TLR4
|
toll-like receptor 4
|
1.894
|
|
CAGE1
|
cancer antigen 1
|
1.891
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
1.877
|
|
CRH
|
corticotropin releasing hormone
|
1.875
|
|
GOT2
|
glutamic-oxaloacetic transaminase 2, mitochondrial
|
1.873
|
|
IL1A
|
interleukin 1, alpha
|
1.861
|
|
GPT2
|
glutamic pyruvate transaminase (alanine aminotransferase) 2
|
1.858
|
|
VPS26C
|
VPS26 endosomal protein sorting factor C
|
1.832
|
|
CELA1
|
chymotrypsin-like elastase family, member 1
|
1.821
|
|
CKM
|
creatine kinase, muscle
|
1.82
|
|
POMC
|
proopiomelanocortin
|
1.82
|
|
CKMT2
|
creatine kinase, mitochondrial 2 (sarcomeric)
|
1.812
|
|
CKMT1B
|
creatine kinase, mitochondrial 1B
|
1.811
|
|
CKB
|
creatine kinase, brain
|
1.808
|
|
TTR
|
transthyretin
|
1.794
|
|
HTR4
|
5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled
|
1.794
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
1.776
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
1.76
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
1.757
|
|
LIPN
|
lipase, family member N
|
1.752
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
1.731
|
|
PCSK5
|
proprotein convertase subtilisin/kexin type 5
|
1.731
|
|
CCK
|
cholecystokinin
|
1.729
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
1.727
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
1.724
|
|
MAPK8IP1
|
mitogen-activated protein kinase 8 interacting protein 1
|
1.72
|
|
CELA3B
|
chymotrypsin-like elastase family, member 3B
|
1.712
|
|
AVP
|
arginine vasopressin
|
1.705
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
1.694
|
|
HMOX1
|
heme oxygenase 1
|
1.684
|
|
TGFB1
|
transforming growth factor, beta 1
|
1.671
|
|
CRHR2
|
corticotropin releasing hormone receptor 2
|
1.67
|
|
RFLNB
|
refilin B
|
1.669
|
|
IL17A
|
interleukin 17A
|
1.668
|
|
KRT20
|
keratin 20, type I
|
1.664
|
|
CLCA1
|
chloride channel accessory 1
|
1.65
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
1.647
|
|
CHAT
|
choline O-acetyltransferase
|
1.647
|
|
CD8A
|
CD8a molecule
|
1.638
|
|
CD34
|
CD34 molecule
|
1.628
|
|
BCHE
|
butyrylcholinesterase
|
1.625
|
|
IL2
|
interleukin 2
|
1.622
|
|
PYY
|
peptide YY
|
1.617
|
|
ACE
|
angiotensin I converting enzyme
|
1.615
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
1.605
|
|
CLCA4
|
chloride channel accessory 4
|
1.602
|
|
MBOAT4
|
membrane bound O-acyltransferase domain containing 4
|
1.601
|
|
SLC26A3
|
solute carrier family 26 (anion exchanger), member 3
|
1.598
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
1.595
|
|
ICAM1
|
intercellular adhesion molecule 1
|
1.584
|
|
KRT7
|
keratin 7, type II
|
1.573
|
|
AFP
|
alpha-fetoprotein
|
1.571
|
|
REN
|
renin
|
1.569
|
|
IL4
|
interleukin 4
|
1.561
|
|
LTF
|
lactotransferrin
|
1.557
|
|
ACE2
|
angiotensin I converting enzyme 2
|
1.542
|
|
SYP
|
synaptophysin
|
1.54
|
|
TACR1
|
tachykinin receptor 1
|
1.54
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
1.528
|
|
NPY
|
neuropeptide Y
|
1.525
|
|
HMOX2
|
heme oxygenase 2
|
1.521
|
|
REG3A
|
regenerating islet-derived 3 alpha
|
1.509
|
|
CDX2
|
caudal type homeobox 2
|
1.505
|
|
RAB11B
|
RAB11B, member RAS oncogene family
|
1.502
|
|
CHGA
|
chromogranin A
|
1.5
|
|
JAK2
|
Janus kinase 2
|
1.499
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
1.497
|
|
HTR2B
|
5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled
|
1.486
|
|
PNLIP
|
pancreatic lipase
|
1.486
|
|
OCLN
|
occludin
|
1.477
|
|
PRSS1
|
protease, serine, 1 (trypsin 1)
|
1.474
|
|
KLK3
|
kallikrein-related peptidase 3
|
1.465
|
|
SCT
|
secretin
|
1.459
|
|
CD68
|
CD68 molecule
|
1.452
|
|
IL13
|
interleukin 13
|
1.451
|
|
PIK3C2A
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha
|
1.451
|
|
PDPN
|
podoplanin
|
1.441
|
|
TLR2
|
toll-like receptor 2
|
1.437
|
|
HP
|
haptoglobin
|
1.436
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
1.436
|
|
NTS
|
neurotensin
|
1.436
|
|
MYD88
|
myeloid differentiation primary response 88
|
1.428
|
|
PTPRN
|
protein tyrosine phosphatase, receptor type, N
|
1.424
|
|
EGFR
|
epidermal growth factor receptor
|
1.422
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
1.419
|
|
SI
|
sucrase-isomaltase (alpha-glucosidase)
|
1.416
|
|
NCAM1
|
neural cell adhesion molecule 1
|
1.41
|
|
GLP2R
|
glucagon-like peptide 2 receptor
|
1.408
|
|
PPIG
|
peptidylprolyl isomerase G (cyclophilin G)
|
1.403
|
|
TJP1
|
tight junction protein 1
|
1.401
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
1.398
|
|
S100B
|
S100 calcium binding protein B
|
1.396
|
|
KNG1
|
kininogen 1
|
1.396
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
1.394
|
|
ANK1
|
ankyrin 1, erythrocytic
|
1.394
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
1.388
|
|
ADM
|
adrenomedullin
|
1.388
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
1.388
|
|
MGAM
|
maltase-glucoamylase
|
1.387
|
|
CD274
|
CD274 molecule
|
1.385
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
1.383
|
|
SLC4A4
|
solute carrier family 4 (sodium bicarbonate cotransporter), member 4
|
1.379
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
1.378
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
1.373
|
|
TP53
|
tumor protein p53
|
1.373
|
|
SCNN1B
|
sodium channel, non voltage gated 1 beta subunit
|
1.368
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
1.362
|
|
PPY
|
pancreatic polypeptide
|
1.36
|
|
MYH14
|
myosin, heavy chain 14, non-muscle
|
1.354
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
1.354
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
1.351
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
1.35
|
|
JUN
|
jun proto-oncogene
|
1.348
|
|
NUCB2
|
nucleobindin 2
|
1.341
|
|
CLCA2
|
chloride channel accessory 2
|
1.338
|
|
IL1R1
|
interleukin 1 receptor, type I
|
1.336
|
|
IL18
|
interleukin 18
|
1.333
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
1.332
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
1.33
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
1.328
|
|
TRH
|
thyrotropin-releasing hormone
|
1.327
|
|
CALB2
|
calbindin 2
|
1.325
|
|
CLDN2
|
claudin 2
|
1.324
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
1.323
|
|
UCN
|
urocortin
|
1.322
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
1.322
|
|
HMGB1
|
high mobility group box 1
|
1.321
|
|
CLCN2
|
chloride channel, voltage-sensitive 2
|
1.318
|
|
VWF
|
von Willebrand factor
|
1.313
|
|
PTH
|
parathyroid hormone
|
1.313
|
|
PRCC
|
papillary renal cell carcinoma (translocation-associated)
|
1.311
|
|
DPP4
|
dipeptidyl-peptidase 4
|
1.305
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
1.301
|
|
ELANE
|
elastase, neutrophil expressed
|
1.298
|
|
MB
|
myoglobin
|
1.298
|
|
GLP1R
|
glucagon-like peptide 1 receptor
|
1.296
|
|
INSM1
|
insulinoma-associated 1
|
1.294
|
|
IL5
|
interleukin 5
|
1.293
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
1.285
|
|
LEP
|
leptin
|
1.283
|
|
GDNF
|
glial cell derived neurotrophic factor
|
1.283
|
|
KRT222
|
keratin 222, type II
|
1.281
|
|
CALCR
|
calcitonin receptor
|
1.277
|
|
IL22
|
interleukin 22
|
1.274
|
|
PDYN
|
prodynorphin
|
1.271
|
|
SP9
|
Sp9 transcription factor
|
1.266
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
1.263
|
|
MME
|
membrane metallo-endopeptidase
|
1.261
|
|
PRKACG
|
protein kinase, cAMP-dependent, catalytic, gamma
|
1.26
|
|
DKKL1
|
dickkopf-like 1
|
1.26
|
|
RAMP1
|
receptor (G protein-coupled) activity modifying protein 1
|
1.257
|
|
PXDNL
|
peroxidasin-like
|
1.257
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
1.257
|
|
PXDN
|
peroxidasin
|
1.255
|
|
HTR3A
|
5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
|
1.254
|
|
C11ORF65
|
chromosome 11 open reading frame 65
|
1.254
|
|
EPO
|
erythropoietin
|
1.253
|
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta
|
1.25
|
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming
|
1.246
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
1.246
|
|
CLDN1
|
claudin 1
|
1.246
|
|
FOXP3
|
forkhead box P3
|
1.238
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
1.23
|
|
CLDN7
|
claudin 7
|
1.23
|
|
MMP9
|
matrix metallopeptidase 9
|
1.228
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
1.227
|
|
BLVRA
|
biliverdin reductase A
|
1.224
|
|
BMP2
|
bone morphogenetic protein 2
|
1.222
|
|
RD3L
|
retinal degeneration 3-like
|
1.218
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
1.218
|
|
MADCAM1
|
mucosal vascular addressin cell adhesion molecule 1
|
1.212
|
|
TPH1
|
tryptophan hydroxylase 1
|
1.211
|
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha
|
1.209
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
1.206
|
|
FN1
|
fibronectin 1
|
1.202
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
1.198
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
1.198
|
|
HRH2
|
histamine receptor H2
|
1.196
|
|
ACTB
|
actin, beta
|
1.196
|
|
PLG
|
plasminogen
|
1.195
|
|
MUC20
|
mucin 20, cell surface associated
|
1.193
|
|
ITGAE
|
integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)
|
1.193
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
1.191
|
|
DNASE1
|
deoxyribonuclease I
|
1.189
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
1.189
|
|
EGF
|
epidermal growth factor
|
1.188
|
|
PRKG2
|
protein kinase, cGMP-dependent, type II
|
1.185
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
1.177
|
|
TH
|
tyrosine hydroxylase
|
1.169
|
|
IFNA2
|
interferon, alpha 2
|
1.169
|
|
ACTG2
|
actin, gamma 2, smooth muscle, enteric
|
1.168
|
|
LY96
|
lymphocyte antigen 96
|
1.166
|
|
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8
|
1.165
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
1.163
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
1.158
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
1.156
|
|
IFNA1
|
interferon, alpha 1
|
1.154
|
|
GIP
|
gastric inhibitory polypeptide
|
1.154
|
|
PLAT
|
plasminogen activator, tissue
|
1.153
|
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4
|
1.152
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
1.15
|
|
CCL28
|
chemokine (C-C motif) ligand 28
|
1.15
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
1.145
|
|
EDNRB
|
endothelin receptor type B
|
1.145
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
1.145
|
|
EMD
|
emerin
|
1.145
|
|
SDC1
|
syndecan 1
|
1.143
|
|
SLC26A6
|
solute carrier family 26 (anion exchanger), member 6
|
1.141
|
|
CCKAR
|
cholecystokinin A receptor
|
1.14
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
1.14
|
|
RET
|
ret proto-oncogene
|
1.139
|
|
TACR2
|
tachykinin receptor 2
|
1.137
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
1.134
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
1.132
|
|
MUC1
|
mucin 1, cell surface associated
|
1.127
|
|
ORM2
|
orosomucoid 2
|
1.125
|
|
PRSS58
|
protease, serine, 58
|
1.125
|
|
CD163
|
CD163 molecule
|
1.122
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
1.111
|
|
UGT1A8
|
UDP glucuronosyltransferase 1 family, polypeptide A8
|
1.11
|
|
AOC1
|
amine oxidase, copper containing 1
|
1.108
|
|
LGR5
|
leucine-rich repeat containing G protein-coupled receptor 5
|
1.107
|
|
P2RX2
|
purinergic receptor P2X, ligand gated ion channel, 2
|
1.106
|
|
SCN10A
|
sodium channel, voltage gated, type X alpha subunit
|
1.106
|
|
UGT1A7
|
UDP glucuronosyltransferase 1 family, polypeptide A7
|
1.104
|
|
UGT1A6
|
UDP glucuronosyltransferase 1 family, polypeptide A6
|
1.103
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
1.102
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
1.101
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
1.098
|
|
NPPB
|
natriuretic peptide B
|
1.097
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
1.095
|
|
MAPK8IP2
|
mitogen-activated protein kinase 8 interacting protein 2
|
1.095
|
|
DEFA5
|
defensin, alpha 5, Paneth cell-specific
|
1.093
|
|
ORM1
|
orosomucoid 1
|
1.091
|
|
FGF7
|
fibroblast growth factor 7
|
1.09
|
|
VIPR1
|
vasoactive intestinal peptide receptor 1
|
1.087
|
|
LCN2
|
lipocalin 2
|
1.082
|
|
TRPC4
|
transient receptor potential cation channel, subfamily C, member 4
|
1.079
|
|
PDCD1
|
programmed cell death 1
|
1.077
|
|
UGT1A4
|
UDP glucuronosyltransferase 1 family, polypeptide A4
|
1.077
|
|
APIP
|
APAF1 interacting protein
|
1.077
|
|
BDNF
|
brain-derived neurotrophic factor
|
1.076
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
1.075
|
|
MRC1
|
mannose receptor, C type 1
|
1.074
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
1.074
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
1.072
|
|
CD19
|
CD19 molecule
|
1.072
|
|
WT1
|
Wilms tumor 1
|
1.068
|
|
UGT1A10
|
UDP glucuronosyltransferase 1 family, polypeptide A10
|
1.067
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
1.066
|
|
PDE5A
|
phosphodiesterase 5A, cGMP-specific
|
1.066
|
|
IFRD1
|
interferon-related developmental regulator 1
|
1.064
|
|
ELAVL3
|
ELAV like neuron-specific RNA binding protein 3
|
1.062
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
1.06
|
|
ESR1
|
estrogen receptor 1
|
1.059
|
|
ABCE1
|
ATP-binding cassette, sub-family E (OABP), member 1
|
1.056
|
|
MAOB
|
monoamine oxidase B
|
1.054
|
|
SERPINA11
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 11
|
1.054
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
1.054
|
|
ALG2
|
ALG2, alpha-1,3/1,6-mannosyltransferase
|
1.053
|
|
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64)
|
1.053
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
1.052
|
|
EHF
|
ets homologous factor
|
1.051
|
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1
|
1.051
|
|
CTRB2
|
chymotrypsinogen B2
|
1.05
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
1.046
|
|
CTRB1
|
chymotrypsinogen B1
|
1.044
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
1.044
|
|
SLC18A3
|
solute carrier family 18 (vesicular acetylcholine transporter), member 3
|
1.043
|
|
SLC9A2
|
solute carrier family 9, subfamily A (NHE2, cation proton antiporter 2), member 2
|
1.043
|
|
GPR39
|
G protein-coupled receptor 39
|
1.042
|
|
F11R
|
F11 receptor
|
1.037
|
|
IFNA10
|
interferon, alpha 10
|
1.037
|
|
IFNA6
|
interferon, alpha 6
|
1.036
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
1.036
|
|
NPPA
|
natriuretic peptide A
|
1.035
|
|
FGF4
|
fibroblast growth factor 4
|
1.035
|
|
LRP5
|
low density lipoprotein receptor-related protein 5
|
1.034
|
|
KIF26A
|
kinesin family member 26A
|
1.031
|
|
IFNA4
|
interferon, alpha 4
|
1.031
|
|
B2M
|
beta-2-microglobulin
|
1.027
|
|
IFNA16
|
interferon, alpha 16
|
1.023
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
1.023
|
|
IFNA21
|
interferon, alpha 21
|
1.022
|
|
IFNA7
|
interferon, alpha 7
|
1.022
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
1.022
|
|
IFNA14
|
interferon, alpha 14
|
1.022
|
|
TTC7A
|
tetratricopeptide repeat domain 7A
|
1.022
|
|
IFNA8
|
interferon, alpha 8
|
1.021
|
|
HTR1B
|
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled
|
1.021
|
|
IFNA5
|
interferon, alpha 5
|
1.02
|
|
IFNA13
|
interferon, alpha 13
|
1.019
|
|
CXCL2
|
chemokine (C-X-C motif) ligand 2
|
1.019
|
|
MAOA
|
monoamine oxidase A
|
1.017
|
|
PRTN3
|
proteinase 3
|
1.017
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
1.013
|
|
ARRB2
|
arrestin, beta 2
|
1.01
|
|
ACR
|
acrosin
|
1.008
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
1.007
|
|
VIPR2
|
vasoactive intestinal peptide receptor 2
|
1.006
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
1.005
|
|
ELN
|
elastin
|
1.004
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
1.002
|
|
RETNLB
|
resistin like beta
|
1.0
|
